Global Allergy Diagnostic Market Forecast to 2031
Analysis based on 20 articles · First reported Feb 17, 2026 · Last updated Mar 19, 2026
The allergy diagnostic market is projected to grow significantly, reaching USD 10.77 billion by 2031, driven by increasing allergic disorders globally. This growth presents substantial opportunities for companies like Thermo Fisher Scientific Inc., Siemens Healthineers AG, and Danaher Corporation, particularly in the Asia-Pacific region.
MarketsandMarkets has published a comprehensive report forecasting the global allergy diagnostic market to grow from USD 6.80 billion in 2026 to USD 10.77 billion by 2031, at a CAGR of 9.6%. The growth is attributed to a worldwide rise in allergic disorders such as allergic rhinitis, asthma, and food allergies, influenced by genetic and environmental factors like urbanization and pollution. The consumables segment is expected to maintain its lead, accounting for 60% of the market in 2025, due to single-use design and frequent replenishment needs. In vivo testing dominated the market in 2025, offering broad allergen coverage and diagnostic efficiency. The Asia-Pacific region is anticipated to exhibit the highest growth rate, with a CAGR of 10.4%, due to increasing allergic conditions and large populations in countries like China and India. Top companies in this market include Thermo Fisher Scientific Inc., Siemens Healthineers AG, and Danaher Corporation.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard